Desmopressin is a relatively safe drug for use, but it still requires the efforts of an interprofessional healthcare team for optimal therapeutic success. This team will include clinicians, specialists, mid-level practitioners, nurses, and pharmacists, coordinating their activities and sharing information to achieve the best patient outcomes. [Level 5]

Patients receiving desmopressin to treat hemophilia A or von Willebrand disease can remain at risk of bleeding. As such, these patients require an integrated and cohesive team of specialists consisting of the primary care physician, hematologist, and in some instances, a gynecologist and geneticist. The primary care physician must ensure that the patients are regularly following up with a hematologist or a hemophilia treatment center. In cases of pregnancy, a woman can receive genetic counseling either before becoming pregnant or later on during the pregnancy.